Experimental ALS drug OK'd by Health Canada

Health Canada has approved an experimental drug for amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, as uncertainty persists about the drug's clinical benefit.

Source: CBC | Health - June 13, 2022 Category: Consumer Health News Tags: News/Health Source Type: news